Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • SDS Manager Reviews & Ratings
    4 Ratings
    Company Website
  • Infor M3 Reviews & Ratings
    152 Ratings
    Company Website
  • ToogleBox Reviews & Ratings
    75 Ratings
    Company Website
  • AlisQI Reviews & Ratings
    92 Ratings
    Company Website
  • Quick Consols Reviews & Ratings
    49 Ratings
    Company Website
  • ManageEngine ADAudit Plus Reviews & Ratings
    516 Ratings
    Company Website
  • Visual Visitor Reviews & Ratings
    250 Ratings
    Company Website
  • Humanly Reviews & Ratings
    119 Ratings
    Company Website
  • Kudoboard Reviews & Ratings
    2,289 Ratings
    Company Website
  • InEight Reviews & Ratings
    129 Ratings
    Company Website

What is SILCS?

Site-Identification by Ligand Competitive Saturation (SILCS) generates three-dimensional representations called FragMaps, which depict the interactions of various chemical functional groups with a designated target molecule. By uncovering the intricacies of molecular dynamics, SILCS provides essential tools that facilitate the refinement of ligand scaffolds, offering both qualitative and quantitative perspectives on binding sites, which ultimately aids in optimizing the drug design workflow. This methodology utilizes a selection of small molecule probes, each possessing a variety of functional groups, along with explicit solvent modeling and the flexibility of the target molecule to effectively map protein targets. Moreover, the technique empowers researchers to visualize beneficial interactions with the target macromolecule, allowing for a more informed design process. Armed with these insights, scientists can strategically engineer enhanced ligands with functional groups positioned for maximum efficacy. The pioneering approach of SILCS marks a noteworthy leap forward in the realm of medicinal chemistry, opening new avenues for drug discovery and development. Through its advanced analytical capabilities, SILCS not only enhances understanding but also drives innovation in therapeutic design.

What is Bruker Drug Discovery?

The journey of bringing a new drug to market involves a complex, time-consuming, and expensive process that is subject to stringent regulations, often taking more than ten years to complete. The success of this venture largely depends on the early acquisition of accurate analytical data, which is essential for making informed choices during the early phases of development and for minimizing the chances of failures in later stages. Typically, the modern drug development process adheres to a systematic approach, starting with the identification of a biological target that becomes the centerpiece of the research efforts. This foundational step requires a deep understanding of the properties of potential candidates to efficiently and effectively identify the most promising options. Once the biological target is identified, the subsequent challenge is to find the most advantageous lead molecules, which includes discovering potential drug candidates that may consist of small organic compounds or biologic entities that show therapeutic potential. Additionally, this entire process highlights the necessity for cross-disciplinary collaboration and innovative thinking, emphasizing the intricate nature of converting a scientific concept into an effective medication. Ultimately, the path from idea to treatment is not just about scientific discovery but also about navigating the complexities of regulatory landscapes and market dynamics.

What is Aurora Drug Discovery?

Aurora applies concepts from quantum mechanics and thermodynamics alongside an advanced continuous water model to evaluate solvation effects when determining the binding affinities of ligands. This approach is notably different from the conventional scoring functions that are commonly used to predict binding affinities. By incorporating both entropy and aqueous electrostatic elements into their calculations, the algorithms developed by Aurora provide notably more accurate and dependable estimates of binding free energies. The binding free energy, a key thermodynamic measure, fundamentally dictates the interaction between a ligand and a protein and is directly associated with the experimentally measurable inhibition constant (IC50). Various elements, such as electrostatic interactions, quantum phenomena, solvation dynamics, and the statistical behavior of molecules, all play a role in influencing this free energy (F). The non-additive characteristics of F arise primarily from two key components: the synergistic effects of electrostatic and solvation energies, as well as the entropy present in the system. Gaining a comprehensive understanding of these factors enhances the insight into the molecular interactions that are crucial for effective drug design and development.

Media

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

Has API

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

SilcsBio

Date Founded

2012

Company Location

United States

Company Website

silcsbio.com/software/

Company Facts

Organization Name

Bruker

Date Founded

1960

Company Location

United States

Company Website

www.bruker.com/en/applications/pharma/drug-discovery.html

Company Facts

Organization Name

Aurora Fine Chemicals

Date Founded

1990

Company Location

United States

Company Website

aurorafinechemicals.com/drug-discovery-software.html

Categories and Features

Categories and Features

Categories and Features

Popular Alternatives

Aurora Drug Discovery Reviews & Ratings

Aurora Drug Discovery

Aurora Fine Chemicals

Popular Alternatives

Popular Alternatives

SILCS Reviews & Ratings

SILCS

SilcsBio
3decision Reviews & Ratings

3decision

Discngine
LigPlot+ Reviews & Ratings

LigPlot+

EMBL-EBI
SILCS Reviews & Ratings

SILCS

SilcsBio
3decision Reviews & Ratings

3decision

Discngine